SAGE THERAPEUTICS for SAGE THERAPEUTICS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Senate drug pricing provisions and Medicare Part D reforms in reconciliation language. Telehealth Medicare physician reimbursement. H.R.4058/S.2061 - Telemental Health Care Access Act of 2021 to remove barriers to telemental health services for Medicare beneficiaries. H.R.5376 - Inflation Reduction Act of 2022.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE GARNER | — |
| MARGARET MANN New | — |
Health Issues HCR
Mental Health Innovation at large substances - Cares Act. Telehealth and controlled substance prescribing habits for serious mental illness. Extension of Public Health Emergency Act for telehealth. Senate drug pricing reforms under Medicare Part D. TRIPS Waiver. H.R.5376 - Inflation Reduction Act of 2022. Mental Health Care - Major Depressive Disorder and PPD.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE GARNER | — |
| MARGARET MANN New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.